We also observed a significant difference in MAP3K1 mRNA levels in PBMCs between SLE patients with higher disease activity (SLEDAI > 8) and those with lower activity (SLEDAI ≤ 8) (Figure 3(b)). The gene discussed is MAP3K1; the disease is systemic lupus erythematosus.